Clinical Trial Update: Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia [Phase 2]

View source ↗

Summary

This is a Phase 2 trial of cyclophosphamide and filgrastim followed by stem cell transplantation in patients with chronic myelogenous leukemia (chronic or accel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelogenous Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Filgrastim (filgrastim)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia | Phase 2 | Status: TERMINATED